Security Snapshot

Legend Biotech Corp - Ordinary Shares (LEGN) Institutional Ownership

CUSIP: 52490G102

13F Institutional Holders and Ownership History from Q2 2020 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

196

Shares (Excl. Options)

87,573,769

Price

$21.74

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Ordinary Shares
Symbol
LEGN on Nasdaq
Shares outstanding
368,659,889
Price per share
$18.09
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
87,573,769
Total reported value
$1,903,451,548
% of total 13F portfolios
0%
Share change
+2,767,259
Value change
+$15,266,968
Number of holders
196
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • LEGN - Legend Biotech Corp - Ordinary Shares is tracked under CUSIP 52490G102.
  • 196 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 196 to 11 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,903,451,548 to $1,344,339.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 196 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 52490G102?
CUSIP 52490G102 identifies LEGN - Legend Biotech Corp - Ordinary Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Legend Biotech Corp - Ordinary Shares (LEGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13% -13% $1,049,921,245 -$147,815,434 48,294,445 -12% FMR LLC 31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.7% $233,379,028 6,808,023 T. Rowe Price Associates, Inc. 31 Dec 2024

As of 31 Dec 2025, 196 institutional investors reported holding 87,573,769 shares of Legend Biotech Corp - Ordinary Shares (LEGN). This represents 24% of the company’s total 368,659,889 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Legend Biotech Corp - Ordinary Shares (LEGN) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 6.6% 24,268,223 -12% 0.03% $527,591,163
SUVRETTA CAPITAL MANAGEMENT, LLC 1.8% 6,608,629 +73% 3.6% $143,671,594
WESTFIELD CAPITAL MANAGEMENT CO LP 1.7% 6,164,677 +1.2% 0.56% $134,020,083
HHLR ADVISORS, LTD. 1.6% 5,984,550 0% 4.2% $130,104,117
DEERFIELD MANAGEMENT COMPANY, L.P. 1.6% 5,932,000 +100% 1.7% $128,961,680
BlackRock, Inc. 1.2% 4,276,913 -4.8% 0% $92,980,090
Point72 Asset Management, L.P. 0.76% 2,784,806 0.09% $60,541,682
Artisan Partners Limited Partnership 0.64% 2,341,074 -8.1% 0.08% $50,894,949
GOLDMAN SACHS GROUP INC 0.59% 2,174,535 +106% 0.01% $47,274,391
ALLIANCEBERNSTEIN L.P. 0.41% 1,517,067 -7.1% 0.01% $32,981,037
STATE STREET CORP 0.41% 1,516,368 +31% 0% $32,965,840
BRAIDWELL LP 0.35% 1,298,142 -29% 0.9% $28,221,607
Davern Capital Partners, LP 0.29% 1,056,668 0% 7.4% $22,971,962
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 0.26% 956,824 -7% 6.3% $20,801,354
JPMORGAN CHASE & CO 0.26% 945,694 +205% 0% $20,559,386
Capital International Investors 0.26% 941,600 0% 0% $20,470,384
JOHNSON & JOHNSON 0.22% 814,586 0% 3.2% $17,709,100
IvyRock Asset Management (HK) Ltd 0.22% 804,000 -6.2% 9.2% $17,478,960
MARSHALL WACE, LLP 0.21% 755,953 +4130% 0.02% $16,434,418
ArrowMark Colorado Holdings LLC 0.2% 721,790 -23% 0.35% $15,691,715
TWO SIGMA ADVISERS, LP 0.19% 689,600 -4.7% 0.03% $14,991,904
ACADIAN ASSET MANAGEMENT LLC 0.16% 582,154 0.02% $12,647,000
Hudson Bay Capital Management LP 0.16% 575,000 +161% 0.07% $12,500,500
GEODE CAPITAL MANAGEMENT, LLC 0.15% 555,436 +2.9% 0% $11,980,293
TWO SIGMA INVESTMENTS, LP 0.14% 526,070 +46% 0.02% $11,436,762

Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 74,254 $1,344,339 -$68,993 $18.09 11
2025 Q4 87,573,769 $1,903,451,548 +$15,266,968 $21.74 196
2025 Q3 83,685,243 $2,727,887,108 -$49,026,070 $32.61 198
2025 Q2 84,637,633 $3,002,800,929 -$25,701,898 $35.49 209
2025 Q1 85,585,612 $2,906,390,112 -$451,293,431 $33.93 205
2024 Q4 99,259,008 $3,230,144,565 +$188,311,867 $32.54 205
2024 Q3 91,083,902 $4,438,353,408 +$43,810,918 $48.73 204
2024 Q2 91,534,759 $4,053,943,715 +$152,693,975 $44.29 173
2024 Q1 86,480,093 $4,850,469,897 +$24,114,634 $56.09 187
2023 Q4 85,815,138 $5,163,245,741 -$85,151,940 $60.17 204
2023 Q3 85,989,090 $5,775,420,098 +$112,052,258 $67.17 198
2023 Q2 84,064,242 $5,802,906,378 +$1,140,343,215 $69.03 191
2023 Q1 68,026,089 $3,279,762,243 +$214,876,512 $48.22 158
2022 Q4 63,494,614 $3,169,508,515 -$28,958,118 $49.92 167
2022 Q3 63,810,382 $2,603,349,501 +$399,712,134 $40.80 154
2022 Q2 52,707,652 $2,898,825,468 +$118,361,366 $55.00 147
2022 Q1 51,010,221 $1,853,796,102 +$18,669,383 $36.34 137
2021 Q4 50,201,932 $2,340,358,513 +$500,109,001 $46.61 137
2021 Q3 39,005,848 $1,971,657,000 +$572,564,727 $50.56 87
2021 Q2 28,328,593 $1,162,838,000 +$121,639,656 $41.05 84
2021 Q1 26,391,052 $765,864,420 +$30,109,528 $29.02 69
2020 Q4 25,444,505 $716,732,000 +$16,894,703 $28.16 60
2020 Q3 24,479,702 $752,680,000 -$30,044,903 $30.87 50
2020 Q2 24,613,241 $1,036,097,000 +$1,036,097,000 $42.56 76

Sponsored